PubChem compound: 37464
Penbutolol is a β-1, β-2 (nonselective) adrenergic receptor antagonist. The β-blocking potency of penbutolol is approximately 4 times that of propranolol. Penbutolol is used for the management of mild to moderate arterial hypertension, alone or in combination with other antihypertensive agents.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C07AA23 | Penbutolol | C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AA Beta blocking agents, non-selective |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| LEVATOL Tablet | Web Search | MPI, US: SPL/Old |
Penbutolol is an active ingredient of these brands:
Turkey (TR)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
